Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2006 Jan;24(1):85-8.
doi: 10.1007/s10637-005-4543-z.

Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma

Jacqueline Vuky  1 , Christina Isacson, Mehran Fotoohi, Jason dela Cruz, Henry Otero, Vincent Picozzi, Thomas Malpass, David Aboulafia, Andrew Jacobs
Affiliations
Clinical Trial

Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma

Jacqueline Vuky et al. Invest New Drugs. 2006 Jan.

Abstract

Fourteen patients with metastatic renal cell carcinoma (RCC) were treated on a Phase II trial with imatinib. Eligible patients had histologically confirmed RCC, metastatic and measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST), Karnofsky performance status (KPS) of at least 70%, life expectancy of more than 3 months, and adequate hematological, renal, and liver function. Imatinib was given orally at a dose of 400 mg bid. The most common toxicities were Grade II/III nausea (28%) and Grade II renal insufficiency (14%). All patients had tumor tested by immunohistochemistry (IHC) for KIT protein (CD117, DAKO). One tumor (7%) demonstrated strong, diffuse expression and the rest were negative. No complete or partial responses were observed in 12 evaluable patients treated with imatinib.

PubMed Disclaimer

References

    1. J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16 - PubMed
    1. N Engl J Med. 1996 Sep 19;335(12):865-75 - PubMed
    1. J Urol. 1997 Jun;157(6):2345-50 - PubMed
    1. Pathol Res Pract. 1993 Sep;189(8):862-6 - PubMed
    1. N Engl J Med. 2002 Aug 15;347(7):472-80 - PubMed

Publication types

LinkOut - more resources